Stock PHARMING GROUP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News PHARMING GROUP Euronext Amsterdam

Equities

NL0000377018

End-of-day quote Euronext Amsterdam
Other stock markets
- EUR - Intraday chart for PHARMING GROUP
05-08 Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024
05-08 Pharming Group N.V. Provides Revenue Guidance for 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pharming N : 1Q 2024 financial results - Analyst & Investor Call transcript
PU
Pharming N : Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
PU
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
GL
Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024
Pharming N : 1Q 2024 Financial Results Presentation - May 8, 2024
PU
Pharming Group reports first quarter 2024 financial results and provides business update
AQ
Pharming Group reports first quarter 2024 financial results and provides business update
GL
Pharming Group N.V. Provides Revenue Guidance for 2024
CI
Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K
PU
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders 2024 Rare Impact Awards
AQ
Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K
PU
Pharming N : Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
PU
Pharming Group to report first quarter 2024 financial results on May 8
GL
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
GL
Pharming Group to Buy Back EUR123 Million of Bonds due 2025
MT
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
GL
Pharming N : Pharming Group announces the placement of €100 million convertible bonds due 2029
PU
Pharming Group announces the placement of €100 million convertible bonds due 2029
GL
Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. Stock
  5. News PHARMING GROUP
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW